Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin 2 and its receptor: structure, function and therapeutic potential.

M Malkovský1, P M Sondel

  • 1MRC Clinical Research Centre, Harrow, Middlesex, UK.

Blood Reviews
|December 1, 1987
PubMed
Summary

This review details human interleukin 2 (IL-2) and its receptor, focusing on applications in cancer therapy. Understanding IL-2 signaling offers new ways to manipulate immune responses for clinical benefit.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody landscape of C57BL/6 mice cured of B78 melanoma via immunotherapy.

bioRxiv : the preprint server for biology·2023
Same author

Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial.

Cancer immunology, immunotherapy : CII·2023
Same author

Partial break in tolerance of NKG2A<sup>-</sup>/LIR-1<sup>-</sup> single KIR<sup>+</sup> NK cells early in the course of HLA-matched, KIR-mismatched hematopoietic cell transplantation.

Bone marrow transplantation·2017
Same author

Retinoids and in vivo immunity to transplantable tumours: a terra relatively incognita.

Immunology today·2014
Same author

Is immunological tolerance (non-responsiveness) a consequence of interleukin 2 deficit during the recognition of antigen?

Immunology today·2014
Same author

Allele-specific alien-driven diversity, immune responsiveness and MHC-restriction.

Immunology today·2014

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry
  • Clinical Medicine

Background:

  • Interleukin 2 (IL-2) is a critical cytokine in immune regulation.
  • The IL-2 receptor mediates essential cellular signaling pathways.
  • IL-2 has shown significant potential in therapeutic applications, particularly in oncology.

Purpose of the Study:

  • To review the molecular, biochemical, and functional aspects of human IL-2 and its receptor.
  • To explore the clinical relevance and applications of IL-2, especially in cancer treatment.
  • To discuss experimental systems and their translation to clinical settings.

Main Methods:

  • Comprehensive literature review of IL-2 and its receptor.
  • Analysis of experimental data on IL-2 biological and pharmacological effects.

Related Experiment Videos

  • Discussion of clinical case studies and therapeutic strategies involving IL-2.

    • Main Results:

    • Detailed outline of IL-2 and its receptor's key features.
    • Evidence supporting the use of IL-2 in various clinical situations, notably cancer.
    • Identification of potential for manipulating immune responses through IL-2 system understanding.

    Conclusions:

    • A deeper comprehension of the IL-2 system is crucial for advancing immunotherapy.
    • Targeted manipulation of IL-2 signaling can lead to novel therapeutic strategies.
    • IL-2 research holds profound implications for the future of clinical medicine and immune response modulation.